Literature DB >> 10738130

A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer.

H Nakama1, B Zhang, A S Fattah.   

Abstract

This study was carried out to assess, from the viewpoint of cost-effectiveness, the optimum number of faecal specimens to collect for use in immunochemical occult blood testing as a means of screening for colorectal cancer. 3300 asymptomatic individuals were subjects of this study. They gave samples for an immunochemical faecal occult blood test, monohaem and colonoscopy was carried out during a medical check-up. For evaluation of the optimum number of sampling specimens, the results of the first day of sampling, those of the first and second days, and those of samples taken for 3 consecutive days were considered as the single-day method, the 2-day method and the 3-day method respectively. The average cost to detect 1 patient with colorectal cancer, the detection rate and the false-positive rate of these three faecal sample collection methods were evaluated. The average costs for one cancer case detected were calculated as $3,630.68 for the single-day method, $3,350.65 for the 2-day method and $4,136.36 for the 3-day method, respectively. The detection rate and the false-positive rate were calculated as 47 and 3.5% for the single-day method, 82 and 4.7% for the 2-day method and 88 and 5.3% for the 3-day method, respectively. This detection rate was significantly different between the single- and the 2-day methods, as well as between the single- and the 3-day methods (P<0. 05). No significant differences in the false-positive rate amongst the three testing methods were observed. This analysis suggests that a 2-day faecal collection method is recommended for immunochemical occult blood screening by Monohaem from the aspects of cost-effectiveness and diagnostic accuracy.

Entities:  

Mesh:

Year:  2000        PMID: 10738130     DOI: 10.1016/s0959-8049(00)00020-4

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Fecal immunochemical test accuracy in average-risk colorectal cancer screening.

Authors:  Vicent Hernandez; Joaquin Cubiella; M Carmen Gonzalez-Mao; Felipe Iglesias; Concepción Rivera; M Begoña Iglesias; Lucía Cid; Ines Castro; Luisa de Castro; Pablo Vega; Jose Antonio Hermo; Ramiro Macenlle; Alfonso Martínez-Turnes; David Martínez-Ares; Pamela Estevez; Estela Cid; M Carmen Vidal; Angeles López-Martínez; Elisabeth Hijona; Marta Herreros-Villanueva; Luis Bujanda; Jose Ignacio Rodriguez-Prada
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

2.  Characteristics of colorectal tumours in asymptomatic patients with negative immunochemical faecal occult blood test results.

Authors:  Kunihiko Wakamura; Shin-Ei Kudo; Hideyuki Miyachi; Kenta Kodama; Seiko Hayashi; Yasuharu Maeda; Yushi Ogawa; Yuta Kouyama; Shin-Ichi Kataoka; Kazuki Kato; Katsuro Ichimasa; Masashi Misawa; Yuichi Mori; Toyoki Kudo; Takemasa Hayashi; Fumio Ishida; Shogo Ohkoshi
Journal:  Mol Clin Oncol       Date:  2015-07-01

3.  Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test.

Authors:  Motoaki Kuriyama; Jun Kato; Koji Takemoto; Sakiko Hiraoka; Hiroyuki Okada; Kazuhide Yamamoto
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

4.  Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?

Authors:  Hiroki Endo; Takayuki Kato; Eiji Sakai; Leo Taniguchi; Jun Arimoto; Harunobu Kawamura; Takuma Higurashi; Hidenori Ohkubo; Takashi Nonaka; Masataka Taguri; Masahiko Inamori; Takeharu Yamanaka; Takashi Sakaguchi; Yasuo Hata; Hajime Nagase; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2016-04-19       Impact factor: 7.527

Review 5.  Colorectal cancer screening: tests, strategies, and perspectives.

Authors:  Fabrizio Stracci; Manuel Zorzi; Grazia Grazzini
Journal:  Front Public Health       Date:  2014-10-27

6.  Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?

Authors:  G Grazzini; C B Visioli; M Zorzi; S Ciatto; F Banovich; A G Bonanomi; A Bortoli; G Castiglione; L Cazzola; M Confortini; P Mantellini; T Rubeca; M Zappa
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.